Featured Research

from universities, journals, and other organizations

Obese Children At Significantly Greater Risk For Post-adenotonsillectomy Complications

Date:
October 13, 2009
Source:
American Academy of Otolaryngology -- Head and Neck Surgery
Summary:
Obesity in children significantly increases the risk of major and minor respiratory complications following surgery to correct sleep disordered breathing, according to new research.

Obesity in children significantly increases the risk of major and minor respiratory complications following surgery to correct sleep disordered breathing (SDB), according to new research presented at the 2009 American Academy of Otolaryngology-Head and Neck Surgery Foundation (AAO-HNSF) Annual Meeting & OTO EXPO, in San Diego, CA.

The study, which followed the post-operative recovery of 49 obese children compared with a control group, revealed that 75.5 percent of the obese children experienced one or more post-surgical respiratory complications, compared with just 26.5 percent of the control group. Particularly, airway obstruction in the obese was significantly more frequent than that of the control group. Obese children were also more likely to be admitted to the hospital, and had a longer duration of stay.

The likelihood of developing these adverse events was greater as the body mass index increased, and in boys.

Obstructive sleep apnea, the most common type of SDB, occurs when the upper airway obstructs or collapses during sleep, causing a decrease in oxygenation. This can result in cognitive and behavioral consequences in children. The main treatment for SDB in children is to surgically remove the tonsils and adenoids that could obstruct the upper airway.

The authors believe this information impacts the risk/benefit assessment of surgery for SDB in obese populations, especially since the benefit of surgery for this group is limited, if not questionable.


Story Source:

The above story is based on materials provided by American Academy of Otolaryngology -- Head and Neck Surgery. Note: Materials may be edited for content and length.


Cite This Page:

American Academy of Otolaryngology -- Head and Neck Surgery. "Obese Children At Significantly Greater Risk For Post-adenotonsillectomy Complications." ScienceDaily. ScienceDaily, 13 October 2009. <www.sciencedaily.com/releases/2009/10/091007153732.htm>.
American Academy of Otolaryngology -- Head and Neck Surgery. (2009, October 13). Obese Children At Significantly Greater Risk For Post-adenotonsillectomy Complications. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2009/10/091007153732.htm
American Academy of Otolaryngology -- Head and Neck Surgery. "Obese Children At Significantly Greater Risk For Post-adenotonsillectomy Complications." ScienceDaily. www.sciencedaily.com/releases/2009/10/091007153732.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins